The Pros And Cons Of Publishing Non-Interventional Study Data – As Seen By Sanofi & GSK

 
• By Vibha Sharma
  
clinicaltrials.gov
Ethic Committees Expect Non-Interventional Studies To Be Listed On A Public Registry • Source: Alamy

More from Clinical Trials

More from R&D